Stocks to Watch: Horizon Therapeutics, Workday, NetApp, Crowdstrike, Wayfair

By Patrick Chu

Horizon Therapeutics PLC: The Dublin, Ireland, drug developer said it is "engaged in highly preliminary discussions with Amgen Inc., [Johnson & Johnson's] Janssen Global Services, LLC and Sanofi" SA, confirming an earlier Wall Street Journal report on takeover interest. Horizon shares soared 31.4% to $103.50 in U.S. after-hours trading on Tuesday.

Workday Inc.: The payroll and human resources enterprise cloud app company's third-quarter revenue climbed 21% to $1.6 billion, while subscription revenue increased 22% to $1.43 billion. It raised its fiscal 2023 subscription revenue guidance to a range of $5.555 billion to $5.557 billion. Shares gained 5.8% to $151.68 in after-hours trading on Tuesday.

NetApp Inc.: The San Jose cloud-computing company guided for adjusted earnings per share between $5.30 and $5.50 for the year, compared with expectations of $6.76, according to FactSet. Revenue for fiscal 2023 is expected to grow between 2% and 4%, the company said. Shares declined 11% to $63.86 in after-hours trading on Tuesday.

Crowdstrike Holdings Inc.: The Austin, Texas, cybersecurity company predicted revenue of $619.1 million to $628.2 million for the current quarter, which fell short of the $633.9 million consensus estimate. Shares dived 18.8% to $112 in after-hours trading.

Wayfair Inc.: The online furniture retailer reported a bump in sales during the five-day shopping period from Thanksgiving through Cyber Monday. Wayfair recorded a low single-digit sales increase in the U.S. over the same period last year. Repeat customers accounted for 73% of holiday orders for the five-day period, the company said. Shares climbed 11% to $35.01 in after-hours trading Tuesday.

Write to Patrick Chu at [e-mail]

(END) Dow Jones Newswires

November 29, 2022 19:22 ET (00:22 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.